Did you get your copy of the
FenceBuilder Newsletter?

View the latest Fence Builder Newsletter

View all Past Issues here

Cannabis as Medicine? Overview

It is utterly mind-blowing that people have no idea that Cannabis has been part of the medical prescription landscape for over 20 years. That’s right T. G. A (Therapeutic Goods Administration) trialled and approved cannabis based medicines have been available as an option to alleviate, if only in small ways, some of the symptoms of a couple of diseases or help with recovery from treatment. However, the claims of this plant being a ‘miracle cure’ for just about everything, have existed for of 100 years… yet in no credible and advanced research has any of the properties of the Cannabis plant ‘cured’ anything, ever!

There is no argument that some components of this incredibly complex plant can have some therapeutic benefit, be it ever so small, but deriving such from the plant with out co-opting some of the more detrimental components has proven incredibly difficult. On top of that, the evidence emerging from latest science, sees that some of these therapies, do more harm than good, with the temporary alleviating of a symptom on one hand, and incurring along term genetic harm on the other!

Again if facts and evidence matter to your best-practice health care, then this is the space for you. Make informed decisions based on science, and not quackery!

 

heathattack26The conversation around cannabis has shifted dramatically over the past decade. As legalisation sweeps across nations and the substance becomes increasingly normalised, a troubling pattern has emerged in medical research that demands urgent attention. The link between cannabis and heart attack risk has become undeniable, with young, seemingly healthy adults experiencing cardiac events at rates that have left cardiologists alarmed.

The Six-Fold Risk That Changed Everything

In March 2025, research published in JACC Advances sent shockwaves through the medical community. The study examined over 4.6 million adults under the age of 50, people who should be at their cardiovascular peak. These weren’t individuals with pre-existing heart conditions, high blood pressure, or unhealthy cholesterol levels. They didn’t have diabetes. They didn’t smoke tobacco. By every traditional measure, they should have been safe from heart attacks.

Yet those who used cannabis faced a staggering reality: they were more than six times as likely to suffer a heart attack compared to non-users.

The numbers tell an even grimmer story. Cannabis users in this study also demonstrated a four-fold increased risk of stroke, double the risk of heart failure, and triple the risk of dying from cardiovascular events. These aren’t marginal increases. They represent a fundamental threat to heart health that has gone largely unrecognised by the public.

When Daily Use Becomes Deadly: Cannabis and Heart Attack Risk

A separate study examining 430,000 American adults, published in the Journal of the American Heart Association, revealed the dose-dependent nature of cannabis and heart attack risk. Daily users showed 25% higher odds of heart attack and 42% higher odds of stroke compared to those who abstained entirely; the more frequently someone used cannabis, the higher their cardiovascular risk climbed.

What makes these findings particularly significant is their rigour. Researchers controlled for every confounding factor they could identify: tobacco use, alcohol consumption, body mass index, diabetes, physical activity levels. The cardiovascular risks persisted regardless. Even among people who had never touched a cigarette or vaping device, cannabis use independently increased their chances of heart attack and stroke.

How Cannabis Damages Your Heart

Understanding why cannabis harms the heart requires looking at the body’s endocannabinoid system. This complex network of receptors exists throughout the cardiovascular system, including in the heart muscle itself, blood vessel walls, and the cells that line our arteries.

THC, the primary psychoactive compound in cannabis, activates cannabinoid receptors in ways that trigger a cascade of harmful effects. It promotes oxidative stress—essentially, it causes cells to rust from the inside out. It sparks inflammation in blood vessel walls, the first step in atherosclerosis. It interferes with how the heart contracts, reducing its pumping efficiency.

Cannabis also wreaks havoc on the autonomic nervous system, which regulates heart rate and blood pressure. Within minutes of use, heart rate can spike dramatically while blood pressure swings unpredictably. This combination forces the heart to work harder precisely when blood flow may be compromised—a perfect storm for triggering a cardiac event.

Research has documented that the risk of heart attack peaks within the first hour after cannabis use, suggesting an acute trigger effect similar to other major cardiac stressors.

The Stroke Connection You Need to Know

Whilst heart attacks dominate headlines, the cannabis stroke risk deserves equal attention. The same 2025 research found that younger adults who used cannabis had significantly elevated stroke risk, even without traditional risk factors like high blood pressure or tobacco use.

Cannabis appears to affect stroke risk through multiple mechanisms. It can cause blood vessels in the brain to constrict abnormally. It promotes blood clotting. It triggers inflammatory responses in vessel walls. The combination creates dangerous conditions for both ischaemic strokes (caused by blocked blood flow) and potentially haemorrhagic strokes (caused by bleeding).

For young people who believe strokes only affect the elderly, this represents a profound wake-up call. The research demonstrates that cannabis use fundamentally alters cerebrovascular function in ways that put users at immediate risk.

200 Million People Can’t Be Wrong

A meta-analysis examining 24 studies involving approximately 200 million people confirmed what individual studies suggested. Published in the journal Heart, this systematic review found that cannabis users faced a 29% higher risk of acute coronary syndrome, a 20% higher risk of stroke, and. Most alarming, a doubled risk of dying from cardiovascular disease.

These aren’t isolated findings from a single laboratory or region. The research spans multiple countries, diverse populations, and various study designs. Ten studies were conducted in the United States, with additional research from Canada and India. Seven found significant positive associations between cannabis and heart attacks, whilst the pooled data conclusively demonstrated a 50% increased risk.

The consistency across this research is striking. When hundreds of millions of data points from independent studies all point in the same direction, it becomes impossible to dismiss the connection as coincidence.

Vaping and Edibles Won’t Save You

Some advocates have suggested that smoking cannabis specifically poses risks, but that other consumption methods might be safer. The evidence doesn’t support this comforting narrative.

Studies examining cannabis use found elevated cardiovascular risks whether people smoked, vaped, or consumed edibles. Whilst smoking introduces additional particulate matter that damages blood vessels, the fundamental problem lies with THC itself and how it interacts with the cardiovascular system.

Cannabis smoke does contain many of the same toxic compounds as tobacco smoke—particulate matter, oxidant gases, carbon monoxide. These substances activate platelets, promote oxidised cholesterol formation, and trigger inflammatory responses. But even when researchers isolated cannabis users who had never smoked anything, the cardiovascular risks remained significantly elevated.

K2 and Spice: Even More Dangerous

If traditional cannabis poses substantial cardiovascular risks, synthetic cannabinoids represent an exponentially greater danger. Products marketed as K2, Spice, and similar brands contain compounds that are full agonists of cannabinoid receptors—meaning they activate these receptors completely, unlike THC which only partially activates them.

These synthetic substances can be hundreds of times more potent than natural cannabis. They’ve been linked to severe cardiac emergencies including sudden cardiac arrest from dangerous heart rhythm abnormalities, acute heart attacks in otherwise healthy young people, and catastrophic strokes.

Critically, standard drug tests don’t detect synthetic cannabinoids, making it difficult for medical professionals to identify exposure when users present with cardiac emergencies.

Why Doctors Are Sounding the Alarm

As cannabis legalisation expands globally and social attitudes shift towards acceptance, consumption rates have climbed, particularly among younger demographics. The 2025 research reveals that this trend coincides with cardiovascular risks that public health messaging has largely failed to communicate. Understanding cannabis and heart attack risk has become critical for anyone making informed decisions about their health.

The researchers behind these studies have called for cannabis to be treated as a serious cardiovascular risk factor, on par with tobacco smoking, hypertension, and high cholesterol. Dr Ibrahim Kamel, lead author of the landmark 2025 study, stated: “At a policy level, a fair warning should be made so that people who are consuming cannabis know that there are risks.”

Yet public perception lags dangerously behind the science. Legalisation and medical cannabis programmes have inadvertently fostered the belief that cannabis is benign. The cardiovascular research tells a different story entirely.

Is Any Amount Safe? Cannabis and Heart Attack Risk

The dose-dependent relationship observed in multiple studies, where more frequent use correlates with higher cardiovascular risk, suggests there’s no threshold where cannabis and heart attack risk disappears entirely. Daily users face the highest risks, but even occasional use shows elevated cardiovascular danger compared to abstinence.

This presents a clear message: from a cardiovascular standpoint, any cannabis use carries risk. For young people who believe they’re invulnerable, for individuals with undiagnosed heart conditions, for anyone with a family history of cardiovascular disease, that risk could prove fatal.

Where You Stand on the Risk Scale

Cardiovascular disease remains the leading cause of death globally. The addition of cannabis as a significant, modifiable risk factor changes the prevention landscape fundamentally.

Traditional risk factors. Smoking, obesity, sedentary lifestyle, poor diet, hypertension: remain critical. But the emerging evidence demonstrates that cannabis use independently elevates risk, potentially turning someone who would otherwise be safe into someone vulnerable to life-threatening cardiac events.

The research indicates that asking about cannabis use should become standard practice in cardiovascular risk assessment, alongside questions about tobacco, exercise, and family history. For individuals making informed decisions about their health, this information is essential.

Major Medical Organisations Agree

The scientific consensus emerging from this research is unambiguous. Major cardiovascular organisations including the American Heart Association and the American College of Cardiology have published statements acknowledging the cardiovascular risks of cannabis use.

Editorials accompanying the research have called for cannabis to be actively discouraged from a public health standpoint, with particular protection for vulnerable populations. The comparison to tobacco is deliberate. Both substances carry serious cardiovascular risks that public policy should address.

Researchers emphasise the need for continued investigation into mechanisms, dose-response relationships, and population-specific vulnerabilities. But the foundation of evidence is already substantial enough to warrant serious concern and immediate public health action.

The Bottom Line on Cannabis and Your Heart

This body of research represents a turning point in our understanding of cannabis and cardiovascular health. The evidence is no longer preliminary, isolated, or ambiguous. Multiple large-scale studies involving millions of participants have demonstrated clear, consistent, and alarming associations between cannabis use and serious heart disease.

For individuals, the message is straightforward: cannabis use significantly elevates the risk of heart attack, stroke, heart failure, and cardiovascular death. This risk exists independently of other factors, affects young people who should be at low cardiovascular risk, and increases with frequency of use.

The choice to use cannabis is ultimately personal, but it should be an informed choice based on accurate understanding of genuine risks. The research published in 2024 and 2025 provides that information with unprecedented clarity.

Hearts are remarkable organs, resilient and powerful. But they’re not invincible, and the evidence demonstrates that cannabis use represents a serious, preventable threat to cardiovascular health. In an era where heart disease remains our greatest health challenge, adding unnecessary risk factors makes little sense.

The conversation around cannabis has focused heavily on legalisation, medical applications, and social justice. It’s past time the discussion included the cardiovascular consequences that research has now conclusively documented.

Your heart deserves better than wishful thinking and outdated assumptions. It deserves decisions based on the best available science. And that science speaks clearly about the dangers cannabis poses to cardiovascular health.

References

  1. Kamel I, Mahmoud AK, Twayana AR, et al. Myocardial Infarction and Cardiovascular Risks Associated with Cannabis Use: A Multicenter Retrospective Study. JACC Adv. 2025. https://www.acc.org/About-ACC/Press-Releases/2025/03/17/15/35/Cannabis-Users-Face-Substantially-Higher-Risk
  2. Jeffers AM, Glantz S, Byers AL, Keyhani S. Association of Cannabis Use With Cardiovascular Outcomes Among US Adults. J Am Heart Assoc. 2024;13(5):e030178. https://www.ahajournals.org/doi/10.1161/JAHA.123.030178
  3. Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis. Heart. 2024. https://bmjgroup.com/cannabis-use-linked-to-doubling-in-risk-of-cardiovascular-disease-death/
  4. Chandy M, Jimenez-Tellez N, Wu JC. The relationship between cannabis and cardiovascular disease: clearing the haze. Nat Rev Cardiol. 2025;22:467-481. https://www.nature.com/articles/s41569-025-01121-6
Featured Website

World Federation Against Drugs

World Federation Against Drugs (W.F.A.D) Dalgarno Institute is a member of this global initiative. For evidence based data on best practice drug policy in the global context.
Featured Website
Alt Tag

Institute for Behavior and Health

The Institute for Behavior and Health, Inc. is to reduce the use of illegal drugs. We work to achieve this mission by conducting research, promoting ideas that are affordable and scalable...
Featured Website

Drug Free Australia

Drug Free Australia Website. Drug Free Australia is a peak body, representing organizations and individuals who value the health and wellbeing of our nation...
Featured Website

Drug Advisory Council of Australia (D.A.C.A)

Drug Advisory Council of Australia (D.A.C.A) Dalgarno Institute is an executive member of this peak body. For updates on current illicit drug issues.
Featured Website

International Task Force on Strategic Drug Policy

(I.T.F.S.D.P) This international peak body continues to monitor and influence illicit drug policy on the international stage. Dalgarno Institute is a member organisation.
Featured Website

Smart Approaches to Marijuana

Smart Approaches to Marijuana. SAM's leaders are among the world's most prominent voices calling for science-based marijuana education and awareness.

21 Be There

There isn’t merely data sharing - it isn't about promoting a 'one dimensional' legislative solution to a complex problem
Featured Website

Drug Free Futures

Drug Policy Futures believes in engaging in an open dialogue about the strengths and weaknesses of global drug policies...
Featured Website

Action Alcohol

The National Alliance for Action on Alcohol is a national coalition of health and community organisations from across Australia that has been formed with the goal of reducing alcohol-related harm.
Featured Website

Greater Risk

Greater Risk Website - The younger they start the greater the risk...
Featured Website

Rivermend Health

RiverMend Health is a premier provider of scientifically driven, specialty behavioral health services to those suffering from alcohol and drug dependency, dual disorders, eating disorders, obesity and chronic pain.
Featured Website

Evidence-Based Practices Resource Center

SAMHSA is committed to improving prevention, treatment, and recovery support services for mental and substance use disorders.
Featured Website

SAMHSA

SAMHSA is committed to improving prevention, treatment, and recovery support services for mental and substance use disorders.